Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |